A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Clinical trial NCT07062965 · RECRUITING
Trial details
- NCT number
- NCT07062965
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-05
- Primary completion
- 2027-07-22
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.